Medlife, PharmEasy agree to merge; deal may be valued at over $1 bn

E-health companies Medlife and  PharmEasy have agreed for a merger, according to the filings submitted by the companies to the Competition Commission of India (CCI). The proposed combination relates to the acquisition of 100% equity shares of Medlife by API Holdings, the parent of PharmEasy, in return for 19.59% equity share capital, according to the CCI filing. 

The deal values the stake of Medlife shareholders for about $200-$250 mn, The aim is to create one of the largest healthcare companies and the valuation of the combined entity is expected to be over $1 bn

7 views0 comments
  • Amazon Social Icon
  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Instagram

© 2021 by StartupNews. Proudly created in India